Salt Lake City, Utah Background: Prior familial clustering studies have observed an increased risk of eosinophilic esophagitis (EoE) mostly among first-degree relatives, suggesting a genetic contribution to EoE, and twin studies have suggested a powerful contribution from environmental factors. Objective: This study sought to clarify the contribution of genetic factors to EoE through estimation of familial aggregation and risk of EoE in extended relatives. Methods: The Utah Population Database, a population-based genealogy resource linked to electronic medical records for health care systems across the state of Utah, was used to identify EoE cases and age, sex, and birthplace-matched controls at a 5:1 ratio. Logistic regression was used to determine the odds of EoE among relatives of EoE probands compared with the odds of EoE among relatives of controls. Results: There were 4,423 EoE cases and 24,322 controls. The population-attributable risk of EoE was 31% (95% CI, 28% to 34%), suggesting a relatively strong genetic contribution. Risks of EoE were significantly increased among first-degree relatives (odds ratio [OR], 7.19; 95% CI, 5.65-9.14), particularly firstdegree relatives of EoE cases diagnosed <18 years of age (OR, 16.3; 95% CI,3); second-degree relatives (OR, 1.99; 95% CI, 1.49-2.65); and first cousins (OR, 1.35; 95% CI, 1.03-1.77), providing evidence of a genetic contribution. However, spouses of EoE probands were observed to be at increased risk of EoE (OR, 2.86; 95% CI, 1.31-6.25), suggesting either positive assortative mating or a shared environmental contribution to EoE.
There is evidence that family history is a risk factor for EoE, suggesting a genetic contribution to the disease. 4, 5 The risk of EoE in first-degree relatives has been observed to be 10-to 64-fold higher compared with that of the general population, with males being at higher risk than females. 6 However, twins studies have suggested a powerful role for environmental factors. A comparison of the concordance rates for monozygotic twins (57.9 6 9.5%) and dizygotic twins (36.4 6 9.3%) was found to be nonsignificant (P 5 .11), and common environment was found to explain a large proportion, estimated at 81%, of variation in the heritability. 6 Clarification of the contribution to EoE by genetic factors is imperative as candidate gene and other genetic studies of EoE are currently underway (see review article by Rothenberg 7 ). Familial aggregation as an indicator of genetic contribution can be best examined by study of more distantly related cases (eg, affected cousins) who likely do not share a common environment.
The purpose of this study was to estimate the familial clustering patterns and risk of EoE in both close and distant relatives. We have available a unique, population-based genealogy resource that has been linked to electronic medical records for health care systems across the state of Utah that facilitates investigation of familial clustering by disease status.
METHODS The Utah Population Database
The Utah Population Database (UPDB) 8 links genealogy information for the state of Utah to inpatient and outpatient electronic health records for the 2 largest health care systems in the state of Utah, which serve approximately 85% of Utah residents, as well as statewide medical data collected by the Utah Department of Health. Genealogy information was obtained from family 
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EoE: Eosinophilic esophagitis ICD-9: International Classification of Diseases, Ninth Revision OR: Odds ratio PAC: Probability of causation PAR: Population-attributable risk UPDB: Utah Population Database UUHSC: University of Utah Health Sciences Center Hospital and Clinics group sheets of Utah pioneers and their descendants that were collected and computerized in the 1970s and combined with birth certificate information (mother, father, and child) to extend the genealogy to the present day. There are over 9 million unique individual records in the UPDB. The majority of families living in Utah are represented in the UPDB, and most families can be linked across at least 5 generations. 8 Studies have shown that the Utah population is mostly of Northern European descent 9 and has experienced high migration rates and low levels of inbreeding among the founding population. 10 Electronic health records for this study were obtained from the University of Utah Health Sciences Center Hospital and Clinics (UUHSC) and Intermountain Healthcare. Electronic records from UUHSC have been linked to the UPDB back to 1994 for 1.7 million patients. Intermountain Healthcare records have been linked to the UPDB back to 1995 for approximately 4 million records. In addition to electronic medical records from UUHSC and Intermountain Healthcare, statewide hospital discharge summaries (that include comprehensive diagnostic information), collected by the Utah Department of Health and linked to the UPDB, were used for this study. This study was approved by the University of Utah Institutional Review Board and the Resource for Genetic Epidemiological Research, which oversees the UPDB. All data for this project were deidentified, and informed consent from subjects was waived.
Identification of EoE cases
EoE cases were identified using the ICD-9 diagnosis code 530.13 using all available records from 2008 to 2013. Cases were required to be at least 3 years of age at diagnosis of EoE to try to eliminate diagnoses made without endoscopy. As availability of the ICD-9 diagnosis code for EoE is relatively recent, cases with 1 documented diagnosis were included in the analysis. Prior data suggest that the EoE diagnostic code has adequate specificity. 11 As further confirmation of the validity of the ICD-9 code, we reviewed 100 random EoE cases with the ICD-9 diagnostic code of 530.13; EoE was confirmed in 93 of the 100 cases by pathology review (>15 eosinophils per high power field [eos/ hpf]) and symptoms of either dysphagia or chest pain refractory to proton pump inhibitors following consensus diagnostic guidelines for EoE. 12 For cases with multiple diagnoses, the first diagnosis date was used to determine age at diagnosis. To be included in this study, subjects were required to have genealogy information for at least 1 parent or 1 child. There were no exclusion criteria for EoE cases.
Population controls
Controls were selected from the UPDB who had family history information available for at least 1 parent or 1 child. They were matched at a ratio of 5:1 to cases by sex, birth year, birth place (Utah or elsewhere), and absence of a known EoE diagnosis (follow-up information is available on the controls at least until the index cases' diagnostic year); controls were selected without replacement (ie, a control could only be used once). Once controls were selected, relatives of the controls (eg, first-degree relatives) were identified based on the UPDB genealogy, and those relatives with an EoE diagnosis were determined. Hence, controls themselves were free of a known diagnosis of EoE, but there was no restriction on the EoE status of their family members.
Spouses
We also investigated risk of EoE among spouses, who were assumed to be unrelated or distantly related (sixth-or higher degree relative) to the index case or control. Analyses involving spouses were limited to those index cases and controls who had children. Spouses were defined as the married or unmarried coparent with the index cases and controls. Analyses involving sibling spouses also required the sibling and their spouse to have a child, and sibling spouses were defined as spouses of siblings without EoE.
Statistical analysis
An in-house developed software program specifically for analysis of UPDB data as well as the software package R (R version 2.14.2 for Windows 7; R Foundation, Vienna, Austria) was used for all analyses. Familial analyses were done using logistic regression; we report the odds of EoE among relatives of EoE probands compared with the odds of EoE among relatives of the controls. Odds ratios (ORs) are a surrogate for relative risk estimates when the prevalence of the disease is low, as it is for EoE. Model covariates included sex and birth year. All relatives of the EoE cases and matched controls were included systematically in the calculations even if that relative had been counted previously. In families with multiple affected individuals (eg, siblings), each case was included as a separate index case and risk among all siblings of each case was calculated separately. This approach has been shown to lead to an unbiased estimate of familial risk. 13, 14 To account for the nonindependence of observations within kindreds and to match appropriate controls to the EoE cases, we used a random-effects model for each kindred group defined by the nearest female ancestor between a pair of relatives (eg, paternal grandmother for paternal cousins). Odds of EoE were investigated in first-degree relatives, which included parents, siblings, and offspring; second-degree relatives, which included grandparents, grandchildren, aunts/ uncles, and nieces/nephews; third-degree relatives, which were limited to first cousins; fourth-degree relatives, which were limited to first cousins, once removed; and fifth-degree relatives, which were limited to second cousins. In addition, the odds of EoE in spouses and sibling spouses were estimated. As EoE case information is available only since 2008 and electronic medical records are available since approximately 1995, analyses were focused on intragenerational, horizontal relatives (ie, cousins) rather than vertical relatives (ie, great grandparents) as vertical relatives are less likely to have an EoE diagnosis because of the narrow window of diagnostic data available by calendar year.
The incidence rate of EoE in Utah was calculated by estimating the incidence of EoE by year from 2008 to 2013, dividing it by an estimate of the Utah population over the same time frame, and multiplying it by 100,000. Cumulative prevalence rates of EoE were calculated by summing the number of EoE cases over multiyear time periods, dividing it by the estimated Utah population over the same time periods, and multiplying it by 100,000. The Utah population count was determined using all subjects who linked to the UPDB for a given year and who met the genealogy requirement of having family history information for at least 1 parent or child available in the UPDB. Population-attributable risk (PAR) of EoE, or the proportion of EoE that is related to familial clustering, was calculated using a method by Bruzzi et al. 15 For each EoE proband, the probability that EoE was caused by membership in a kindred was calculated using High-risk EoE pedigrees were determined by identifying founders with an excess number of affected descendants compared with the expected number of affected descendants based on population rates of EoE based on age-and sex-matched cohorts (P < .01). High-risk pedigrees were further determined by requiring that the pedigree's familial standardized incidence ratio be >5, which accounts for the number of relatives in the pedigree, degree of relatedness to the proband, and person-time at risk among family members. 16 
RESULTS
There were 5,138 unique EoE subjects identified in the UPDB, 4,423 of these subjects had at least 1 relative in the UPDB and were defined as probands for this study. These 4,423 EoE cases were age-, sex-, and birthplace-matched to 24,322 controls. Demographic characteristics of cases by sex are displayed in Table I . Nearly twice as many diagnosed EoE cases were male. The mean age at diagnosis was 36.2 years for males and 38.6 years for females.
Incidence rates and cumulative prevalence rate by year and by age (<18 and > _18 years) are shown in Table II positive assortative mating or a contribution from shared environmental factors to EoE. However, the total number of spouses (10 total individuals or 5 husband-wife pairs) who were both affected with EoE was small (0.39%).
Further exploration of the risk of EoE in relatives stratified by age of the proband (<18 and > _18 years) is shown in Table IV . There were 813 probands diagnosed with EoE prior to the age of 18 years identified. Among these earlier diagnosed EoE probands, there was a greatly increased risk of EoE among first-degree relatives of any age (OR, 16.3; 95% CI, 9.4-28.3; P 5 3.3E-23) and an increased risk of EoE among second-degree relatives (OR, 2.02; 95% CI, 1.06-3.86; P 5 .032), but no increased risk was observed for other more distant relatives. When first-degree relatives of earlier diagnosed probands were restricted to also be <18 years of age (data not shown), the odds of having a diagnosis of EoE increased to 34.44 (95% CI, 15.5-76.54; P < 2E-16), suggesting that siblings of younger EoE cases are at greatly increased risk of EoE. For probands > _18 years of age at diagnosis of EoE (n 5 3610), an increased risk of EoE for first-degree relatives, second-degree relatives, and first cousins was observed. Inclusion of an interaction term in the logistic regression model between age of proband (<18 vs > _18) and affection status of first-degree relative (case vs control) was found to be significant (P 5 2.25E-4), suggesting a significant difference in risk of EoE to first-degree relatives of probands diagnosed at an earlier age.
As males are more likely to be affected with EoE, the odds of diagnosis of EoE among male relatives compared with female relatives in our Utah population was explored (Table V) . As can be seen, males have approximately 1.9 times increased risk of being diagnosed with EoE than do females across all relative types and controls.
The PAR for familial factors contributing to EoE was estimated to be 31% (95% CI, 28% to 34%). The PAR represents the contribution from familial or genetic factors.
DISCUSSION
In this Utah population-based study, we observed evidence of a significant familial clustering of EoE in first-degree relatives, second-degree relatives, and first cousins (a third-degree relative). While familial EoE cases may be attributable to shared genetic factors or shared environmental factors, the excess clustering of EoE in distant relatives, who are less likely to share immediate environments, suggests a genetic contribution to the disease.
A number of prior studies investigating the family history risk of EoE mostly among first-degree relatives have observed an increased risk of EoE. 6, [17] [18] [19] [20] [21] Our study is the first to explore risk of EoE in distant relatives. We report the PAR for familial factors, which indicates the proportion of EoE related to familial causes, to be 31%, which represents a relatively strong contribution from familial/genetic factors. For comparison, the PAR for EoE is similar to the PAR for familial factors for colon cancer calculated using the UPDB, the Utah Cancer Registry, and the same methodology as was used for this study at 32% (95% CI, 26% to 37%). 22 However, given that a substantial proportion of the PAR for EoE is not explained by familial factors, our results are also consistent with a strong contribution from environmental factors. 6 Study of high-risk families with an excess of EoE may facilitate EoE predisposition gene identification. A number of candidate gene studies and genomewide association studies are being conducted to identify EoE risk variants. 7 Extended families with multiple disease cases are a proven means for finding disease-causing genes. 23 Given that environmental effects contribute to EoE, cases recruited from high-risk families, such as the example high-risk pedigree shown in Fig 1, may reduce the chance of sampling sporadic clusters and increase the frequency of shared rare variants within the family and hence increase power to detect the causal variant(s). 24 Early onset disease is sometimes indicative of stronger genetic effects (eg, cancer or Alzheimer disease). 25, 26 However, in this study for early onset probands, we did not observe stronger genetic effects as evidenced by an increased risk of EoE in both close and distant relatives. We observed a greatly increased risk of EoE among first-degree relatives of probands with earlier diagnosed disease (age <18 years), a risk of EoE in seconddegree relatives that was comparable between probands diagnosed at age <18 years and age > _18 years, and no increased risk of EoE in first cousins. This increased risk of EoE in first-degree relatives of earlier onset probands is most likely because siblings with similar symptoms could be more easily diagnosed through prior knowledge of the disease by their parents and treating physicians as well as referrals to specialists who treat EoE, though work remains to validate this explanation. The lack of an increased risk of EoE in more distant relatives may be due to multiple factors including small sample size of earlier onset cases or a relatively new diagnostic code for EoE; further investigation of the risk of EoE in distant relatives of earlier diagnosed probands in the future is warranted as awareness of EoE increases over time.
The increased risk of EoE observed in this study among a small number of unrelated, adult, spouse pairs (5 total spouse pairs, or 10 subjects) is noteworthy. The number of years of marriage prior to EoE diagnosis for these 5 marriages ranged between 6 years and 36 years, and all 5 of the marriages occurred prior to 2008. Given that the ICD-9 code for EoE started in 2008 and that individuals in this study could not have received the ICD-9 diagnostic code prior to 2008, we cannot determine whether the increased risk of EoE observed for spouses is due to shared environmental contributions or assortative mating. Future research involving affected spouse pairs may help to understand this observed increased risk for EoE.
Similar to other studies, 27, 28 we also observed an increased risk of EoE in males. One prior study reported a cohort of EoE patients in which 75% were male. 29 A nonsynonymous single nucleotide polymorphism associated with the thymic were expected based on age-, sex-, and birthplace matched population rates (P 5 .0007). Males are represented as squares, females as circles, and shaded diamonds represent cases. The diamond shape, which is a unisex designation, was used to protect the identity of the pedigree. Slashes indicate individuals who are deceased. As a high-risk pedigree, the number of affected individuals significantly exceeds the number of cases expected.
stromal lymphopoietin (TSLP) receptor gene has been found to be involved in the pathogenesis of EoE; this gene is encoded in the pseudoautosomal regions on the X and Y chromosomes and may account, in part, for the increased frequency in males. 30 It is also possible that there are sex-specific epigenetic modifications that influence gene expression levels resulting in male predominance of EoE.
There are limitations of this study. We used a single occurrence of an ICD-9 code indicating EoE to identify cases. While EoE is a relatively new diagnosis and prior studies indicate that the EoE diagnostic code has adequate specificity, 11 it is possible that some misclassification bias may be present in this study. As a check on misclassification bias, the crude EoE prevalence in controls was reported (Table III) , which should approximate EoE prevalence in the general population. In this study, the crude EoE prevalence in controls ranged from 0.18% to 0.23%. In a study by Ronkainen et al, 31 which estimated prevalence of EoE in a community-based study in Sweden, upper endoscopy was performed on 1000 randomly selected adults; using an EoE diagnostic criterion of >20 eos/hpf, they found prevalence of definite EoE to be 0.4%. The prevalence of EoE in this Swedish community is very similar to our crude EoE prevalence among controls. Given that our sample size of EoE cases was substantial and population-based, the comparability of control prevalence rates suggests that we accurately quantified EoE disease risk in relatives. Another limitation of this study is that because EoE is a relatively new diagnostic code, there may be many undiagnosed EoE cases within the various health care systems used for this study possibly due to delays in diagnosis of EoE, misdiagnosis, as well as symptomatic subjects without a diagnosis of EoE who have not sought medical attention (eg, invasive diagnostic endoscopy required). However, despite the possibility of missing individuals with EoE, our study prevalence estimate is similar to other published prevalence estimates, 3 providing empiric validity for our study. We assumed that missed EoE diagnostic rates were similar between relatives of cases and relatives of controls because they were drawn from the same sample; however, close relatives of an EoE case may be more likely to have a diagnosis of EoE because of prior knowledge of EoE within the family.
The findings from this study are generalizable to other populations of Western and Northern European ancestry. Studies using the UPDB genealogy resource have shown that the Utah population is mostly of northern European descent 9 and has experienced high migration rates and low levels of inbreeding among the founding population. 32 In conclusion, we have identified a significant genetic contribution to EoE that extends to distant relatives. Study of families with an excess of EoE may facilitate EoE predisposition gene identification and hence further understanding of EoE etiology.
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